Real-World Safety and Efficacy Clinical Data of an Improved Allergen-Specific Immunotherapy Product for the Treatment of Bee Venom Allergy

Real-World Safety and Efficacy Clinical Data of an Improved Allergen-Specific Immunotherapy Product for the Treatment of Bee Venom Allergy

The aim of this study is to explore the safety and efficacy of bee venom immunotherapy without HSA, in real-life patients. Methods: This is an observational retrospective study developed in seven hospitals in Spain, where patients treated with this immunotherapy were included. They gathered the prot...

Full description

Bibliographic Details
Main Authors: Luis Alfredo Gonzalez Guzman, Jose Carlos García Robaina, Javier Barrios Recio, Elena Escudero Arias, Tania Liñares Mata, Raquel Cervera Aznar, Federico De La Roca Pinzón, Lissette del Carmen Miguel Polo, Luis Arenas Villarroel, Verónica P. López Couso, Javier Alcover Diaz, David Rodriguez Gil, Ricardo Palacios Pelaez, Francisco Javier Carballada Gonzalez
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Vaccines
Subjects:
hymenoptera venom
allergy immunotherapy
Api m 10
bee venom
human serum albumin
vaccines
Online Access:https://www.mdpi.com/2076-393X/11/5/979

Internet

https://www.mdpi.com/2076-393X/11/5/979

Similar Items